Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 47.43B | 49.13B | 44.36B | 43.13B | 40.49B | 36.03B |
Gross Profit | 8.00B | 8.60B | 6.65B | 6.48B | 6.89B | 5.70B |
EBITDA | 3.27B | 4.21B | 3.03B | 3.51B | 3.80B | 2.98B |
Net Income | 1.24B | 2.01B | 1.06B | 1.29B | 1.47B | 1.32B |
Balance Sheet | ||||||
Total Assets | 40.92B | 39.97B | 38.48B | 34.58B | 33.93B | 31.78B |
Cash, Cash Equivalents and Short-Term Investments | 7.62B | 7.64B | 7.53B | 5.10B | 4.88B | 3.72B |
Total Debt | 8.55B | 8.28B | 8.81B | 8.19B | 7.99B | 8.09B |
Total Liabilities | 21.25B | 19.66B | 19.99B | 18.11B | 18.26B | 17.56B |
Stockholders Equity | 18.72B | 19.31B | 17.57B | 15.40B | 14.33B | 12.99B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.19B | 2.37B | 329.96M | 1.78B | 822.02M |
Operating Cash Flow | 0.00 | 2.35B | 3.46B | 1.55B | 3.34B | 2.44B |
Investing Cash Flow | 0.00 | -1.16B | -2.53B | -775.72M | -1.63B | -1.73B |
Financing Cash Flow | 0.00 | -1.24B | -32.69M | -683.88M | -782.85M | 477.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥15.44B | 7.68 | 3.93% | 10.75% | 287.84% | ||
74 Outperform | ¥3.18B | 5.88 | 2.70% | 2.92% | -6.49% | ||
72 Outperform | ¥13.51B | 7.20 | 4.59% | 2.82% | 127.54% | ||
70 Outperform | ¥2.95B | 9.39 | 3.93% | -1.64% | -44.72% | ||
68 Neutral | £2.95B | 10.28 | 8.40% | 3.21% | 2.87% | -9.95% | |
68 Neutral | ¥3.42B | 8.65 | 1.89% | -7.15% | 39.05% | ||
60 Neutral | ¥4.10B | 58.17 | 3.73% | 0.38% | 24.47% |